EGFR and lung adenocarcinoma: <b>Introduction:</b> Small cell lung cancer (SCLC) transformation represents a mechanism of resistance to osimertinib in <i>EGFR</i>-mutated lung adenocarcinoma, which dramatically impacts patients' prognosis due to high refractoriness to conventional treatments.